Meteorologist John Marcy gives details on upcoming soggy weather. Trump Makes Announcement Against Taliban Your boomer parents are probably living in a house too big for them. They’re frozen in place ...
Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go 'rogue' in many different diseases affecting multiple ...
SANDUSKY, MI — McKenzie Health System will hold a groundbreaking ceremony for its new hospital on Wednesday, Oct. 1, at noon in Sanilac County. The ceremony marks the beginning of construction on the ...
Libby users discovered a new message about the hold system within the app. Credit: Screenshot: Libby The message stated: "Hold suspensions have changed. If you suspend a hold, you should unsuspend it ...
The message stated: "Hold suspensions have changed. If you suspend a hold, you should unsuspend it when you're ready for it. Suspended holds lapse if you do not unsuspend them within a year." This is ...
Until now, pairing was required each time you connected a DualSense or DualSense Edge wireless controller to a different device such as PC, Mac, and mobile devices. With this update, you can now ...
Arizona returned to shells on Friday, but had one of its longest practices of training camp. Arizona men's basketball head coach Tommy Lloyd and the UA basketball players did pre-practice jumping ...
Multiple NFL teams hosting home games during the 1 p.m. window of Sunday's schedule conducted pregame tributes to slain Turning Point USA founder Charlie Kirk. And the reactions in the stadiums were ...
TOLEDO, Ohio — It's almost election season, and the Toledo Lucas County Public Library (TLCPL) is holding events at several branches in order to connect voters with polling information, and, with the ...
Teva Pharmaceuticals (NYSE:TEVA) said that the U.S. FDA has granted fast track designation to its experimental therapy TEV-56286 (emrusolmin) for treating Multiple System Atrophy. Emrusolmin, ...
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development. New ...
Emrusolmin is expected to improve symptoms of MSA by targeting alpha synuclein oligomers. The Food and Drug Administration (FDA) has granted Fast Track designation to emrusolmin (TEV-56286) for the ...